Growth Metrics

Ligand Pharmaceuticals (LGND) Current Taxes (2019 - 2025)

Historic Current Taxes for Ligand Pharmaceuticals (LGND) over the last 6 years, with Q3 2025 value amounting to $1.3 million.

  • Ligand Pharmaceuticals' Current Taxes fell 3908.92% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 3908.92%. This contributed to the annual value of $1.2 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Ligand Pharmaceuticals' Current Taxes stood at $1.3 million, which was down 3908.92% from $305000.0 recorded in Q2 2025.
  • Over the past 5 years, Ligand Pharmaceuticals' Current Taxes peaked at $11.4 million during Q2 2023, and registered a low of $305000.0 during Q2 2025.
  • Over the past 4 years, Ligand Pharmaceuticals' median Current Taxes value was $1.9 million (recorded in 2024), while the average stood at $3.5 million.
  • The largest annual percentage gain for Ligand Pharmaceuticals' Current Taxes in the last 5 years was 20108.41% (2023), contrasted with its biggest fall of 8759.15% (2023).
  • Ligand Pharmaceuticals' Current Taxes (Quarter) stood at $9.7 million in 2022, then crashed by 87.59% to $1.2 million in 2023, then decreased by 0.42% to $1.2 million in 2024, then grew by 7.09% to $1.3 million in 2025.
  • Its Current Taxes was $1.3 million in Q3 2025, compared to $305000.0 in Q2 2025 and $1.8 million in Q1 2025.